TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,580 | -25.8% | 213,085 | -0.4% | 0.00% | – |
| Q2 2023 | $100,532 | -46.4% | 213,898 | -21.8% | 0.00% | – |
| Q1 2023 | $187,388 | -31.3% | 273,441 | +5.3% | 0.00% | – |
| Q4 2022 | $272,780 | -74.1% | 259,790 | +0.3% | 0.00% | – |
| Q3 2022 | $1,052,000 | -28.7% | 259,136 | -0.7% | 0.00% | – |
| Q2 2022 | $1,475,000 | -9.2% | 260,990 | +1.3% | 0.00% | – |
| Q1 2022 | $1,625,000 | -28.9% | 257,670 | +0.1% | 0.00% | – |
| Q4 2021 | $2,284,000 | +14.1% | 257,499 | -0.7% | 0.00% | – |
| Q3 2021 | $2,001,000 | -20.4% | 259,270 | -0.9% | 0.00% | – |
| Q2 2021 | $2,514,000 | -35.0% | 261,514 | -8.2% | 0.00% | – |
| Q1 2021 | $3,867,000 | -3.5% | 284,921 | +1.8% | 0.00% | – |
| Q4 2020 | $4,008,000 | -14.7% | 279,846 | +10.1% | 0.00% | – |
| Q3 2020 | $4,696,000 | +1455.0% | 254,209 | +384.3% | 0.00% | – |
| Q2 2020 | $302,000 | +259.5% | 52,494 | +137.2% | 0.00% | – |
| Q1 2020 | $84,000 | +25.4% | 22,134 | +77.8% | 0.00% | – |
| Q4 2019 | $67,000 | – | 12,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mesirow Financial Investment Management, Inc. | 40,119 | $253,000 | 0.85% |
| GAGNON SECURITIES LLC | 253,019 | $1,597,000 | 0.26% |
| PRINCETON CAPITAL MANAGEMENT LLC | 125,968 | $795,000 | 0.25% |
| DRW Securities, LLC | 1,000,000 | $6,310,000 | 0.17% |
| CARLSON CAPITAL L P | 310,000 | $1,956,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 105,388 | $665,000 | 0.09% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $139,000 | 0.07% |
| Fermata Advisors, LLC | 23,848 | $150,000 | 0.06% |
| SANDERS MORRIS HARRIS LLC | 20,826 | $131,000 | 0.03% |
| Meridian Wealth Advisors, LLC | 11,500 | $73,000 | 0.02% |